Frequency, causes and timing of premature discontinuation of double antiplatelet therapy after drug eluting stents

被引：0
|
作者：
Lozano Martinez-Luengas, I. [1 ]
Garcia, O. C. [1 ]
Torres, F. [1 ]
Carro, A. [1 ]
Bayon, J. [1 ]
Rondan, J. [1 ]
Avanzas, P. [1 ]
Martin, M. [1 ]
De La Hera, J. M. [1 ]
Barriales, V. [1 ]
机构：
[1] Hosp Univ Cent Asturias, Oviedo, Spain
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [41] Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents
    Drewnicki, Andrzej
    Lesiak, Maciej
    Pyda, Malgorzata
    Grygier, Marek
    Skorupski, Wlodzimierz
    Araszkiewicz, Aleksander
    Mitkowski, Przemyslaw
    Grajek, Stefan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B41 - B41
  • [42] Deciphering Dual Antiplatelet Therapy in the Era of Drug-Eluting Coronary Stents
    Bell, Brendan
    Walters, Darren
    Spaulding, Christian
    [J]. CURRENT DRUG TARGETS, 2009, 10 (06) : 519 - 529
  • [43] ETIOLOGY, TIMING AND IMPACT OF DUAL ANTIPLATELET THERAPY DISCONTINUATION AFTER DRUG-ELUTING STENT IMPLANTATION: INSIGHTS FROM THE ADAPT-DES STUDY
    Musikantow, Daniel
    Kirtane, Ajay
    Litherland, Claire
    Witzenbichler, Bernhard
    Weisz, Giora
    Rinaldi, Michael
    Metzger, David
    Henry, Timothy
    Cox, David
    Stuckey, Thomas
    Maehara, Akiko
    Genereux, Philippe
    Mehran, Roxana
    Stone, Gregg
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 186 - 186
  • [44] Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: A retrospective cohort study
    Brotman, Daniel J.
    Bakhru, Mihir
    Saber, Wael
    Aneia, Ashish
    Bhatt, Deepak L.
    Tillan-Martinez, Katherina
    Jaffer, Amir K.
    [J]. JOURNAL OF HOSPITAL MEDICINE, 2007, 2 (06) : 378 - 384
  • [45] Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy
    Varghese, Indu
    Ummer, Ayrin
    Roesle, Michele
    Banerjee, Subhash
    Brilakis, Emmanouil S.
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2008, 9 (03) : 179 - 181
  • [46] Perioperative discontinuation of antiplatelet therapy of patients with coronary stents
    Graw, J.
    Schwenk, W.
    Volk, T.
    [J]. CHIRURG, 2009, 80 (06): : 498 - 501
  • [47] Long term dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomised studies
    Ferrante, G.
    Pisaniello, M.
    Stefanini, G. G.
    Pagnotta, P.
    Reimers, B.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 31 - 31
  • [48] Antiplatelet therapy after implantation of drug-eluting stents: Duration, resistance, alternatives, and, management of surgical patients
    Gurbel, Paul A.
    DiChiara, Joseph
    Tantry, Udaya S.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8B): : 18M - 25M
  • [49] The optimal duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents: an unanswered question
    Aurigemma, Cristina
    Burzotta, Francesco
    Trani, Carlo
    [J]. CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 : S91 - S94
  • [50] Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents
    Ben-Dor, Itsik
    Torguson, Rebecca
    Scheinowitz, Mickey
    Li, Yanlin
    Delhaye, Cedric
    Wakabayashi, Kohei
    Maluenda, Gabriel
    Syed, Asmir I.
    Collins, Sara D.
    Gonzalez, Manuel A.
    Gaglia, Michael A., Jr.
    Xue, Zhenyi
    Kaneshige, Kimberly
    Satler, Lowell F.
    Suddath, William O.
    Kent, Kenneth M.
    Pichard, Augusto D.
    Waksman, Ron
    [J]. AMERICAN HEART JOURNAL, 2010, 159 (05) : 871 - 875
12345